FOXA1 and breast cancer: FOXA1 is required for global ER binding in the MCF7 breast cancer cell line and ER occupancy at >90% of binding events is reduced when FOXA1 is silenced, which correlates with a global loss in the accessibility of chromatin (Hurtado et al., 2011).